Genes

Genes

Made Scientific and Basilard BioTech Collaborate to Accelerate Development of Celletto Gene Delivery Platform

Made Scientific, a leading US-based cell therapy contract development and manufacturing organization (CDMO), and Basilard BioTech, a Southern California biotechnology company, have announced a strategic collaboration to accelerate the development and translation of Basilard BioTech's nanomechanical gene delivery platform, Celletto. Celletto is a disruptive technology that addresses long-standing

Genetic research

Breakthrough in Cancer Gene Therapy: Establishing Clinical-Scale CAR-T Production in Kazakhstan

In a groundbreaking study published in Biomolecules, researchers at the National Center for Biotechnology in Kazakhstan have successfully established a clinical-scale production of CAR-T cell therapy, a revolutionary treatment for cancer. The innovative approach, which involves the in-house production of lentiviral vectors and automated CAR-T cell processing, has overcome significant

Genetic research

Olive Mill Wastewater Emerges as Promising Source for Cosmeceutical and Dermatological Applications

Researchers at the European Institute of Oncology have discovered the potential of olive mill wastewater (OMWW) in developing sustainable and eco-friendly cosmeceutical ingredients. The researchers found that OMWW, a byproduct of olive oil production, contains key polyphenols such as hydroxytyrosol, oleuropein, and tyrosol, which exhibit potent antioxidant, anti-inflammatory, antimicrobial, and

Cancer

Cancer Gene Therapy Market to Reach $13.58 Billion by 2030, Driven by Growing Demand for Pain-Free Treatment and Increased Healthcare Expenditure

The cancer gene therapy market is experiencing significant growth, driven by the growing demand for painless treatment at lower cost, coupled with increasing aesthetic consciousness among the population, significantly increasing the demand for cancer gene therapy across different parts of the globe. The global market for cancer gene therapy was